In a famous paper from the late 1970s, Robin 1 postulated his concerns about overdiagnosis and overtreatment of pulmonary embolism (PE), stating that "the emperor of embolism may have no clothes." He was mainly concerned about overdiagnosing PE in previously healthy young women, arguing that the prior probability of PE is low in these patients, and this subsequently results in a lower positive predictive value of perfusion scans (following Bayes' theorem). Today, concerns about overdiagnosing PE still remain highly relevant. 2 However, in addition to concerns about overdiagnosing PE in young adults, current research also focuses on referring (thus, also overdiagnosing) frail elderly patients too oft en or too soon for suspected PE: Th e naked emperor of embolism is aging. Th e main reason behind this problem comes from the fact that D-dimer testing yields more false-positive results in the elderly as compared with a non-aged population. Th us, many patients need to be referred, and typically only 10% to 15% of these patients have confi rmed PE. Th e use of an age-adjusted cutoff for D-dimer testing (age 3 10 in those aged . 50 years) has been proposed, aiming to reduce this number of false-positive results and, thus, the number of patients for whom imaging (CT pulmonary angiography [CTPA]) is required to confi rm or refute the diagnosis. 3 In this issue of CHEST , Woller et al 4 (see page 1444 ) further expand the evidence behind this so-called age-adjusted cutoff for D-dimer testing. Th ey used a previously described impressive cohort of 3,500 patients with suspected PE 5 and identifi ed a subset of 934 patients aged . 50 years combined with a low risk of acute PE (using a Revised Geneva Score Յ 10). All patients underwent CTPA to confirm or refute a diag nosis of PE. Among these 935 patients, 273 patients (29%) had a D-dimer value below this age-adjusted cutoff . During 90 days of follow-up, only four patients were diagnosed with PE, yielding a failure rate of 1.5% "missed" PE cases (95% CI, 0.4%-3.7%). If the conventional cutoff ( , 500 ng/mL) had been used, only 104 patients (11%) had a negative D-dimer, yet in this group no PE cases were missed. Th us, they demonstrated an almost 20% reduction of required CTPA tests for this age-adjusted cutoff , as compared with the conventional cutoff . Th ese fi ndings-a sharp reduction in CTPA tests at the cost of a slightly higher failure rate-are largely in concurrence with previous studies, including a recent meta-analysis (not yet including the current article from Woller et al 4 ) on this age-adjusted D -dimer cutoff . 6 Now, the question arises: Would this higher failure rate (still) be acceptable in the context of fewer CTPA tests in these elderly patients? Basically, this comes back to answering the following two questions. First, how many additional PE cases are missed, and how many of them are fatal? Second, how many CTPA tests are avoided? Th is is important as at least in some patients CTPA will be performed without PE being present, and these patients are at risk for unnecessary iatrogenic damage from CTPA (including radiation and contrast nephropathy). Ideally, these questions should be addressed in a formal randomized controlled trial (RCT) comparing both diagnostic strategies. However, RCTs comparing diagnostic strategies are in general diffi cult to perform (as well as to fi nance) and for now are lacking. Indirect
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comparisons may, however, be more feasible. For instance, if we compare aggregated data from an also recently published prospective evaluation of the age-adjusted cutoff (the ADJUST-PE study 7 ), plus the study by Woller et al, 4 with a landmark and large-scale diagnostic management study in suspected PE using a conventional cutoff (the Christopher Study 8 ), the following conclusions can be drawn ( Table 1 ) . First, using either a conventional or an age-adjusted cutoff , the proportion of missed PE cases is comparable and small (well below 2%), and no fatal cases occur, which is a reassuring fi nding. Second, more strikingly, the proportion of patients for whom CTPA is still required is also rather comparable: Still around six to seven in every 10 suspected patients require CTPA to confi rm or refute a diagnosis of PE, a fi nding in concurrence with a systematic review on decision rules in suspected PE. 9 Th is leaves us startled. Comparisons within cohorts demonstrate a sharp reduction of required CTPA tests, notably in the eldest elderly. Yet, an indirect comparison over diff erent cohorts does not demonstrate this reduction of CTPA tests. Obviously, inherent problems related to this indirect (nonrandomized) comparison play a role here. Combing individual patient data (IPD) of these studies and using state-of-the-art IPD metaanalysis 10 could allow us to explain these diff erent fi ndings between within and over cohort comparisons. For instance, the number of comorbidities, the applied clinical decision rule, the prevalence of PE in diff erent studies, increasing age, D -dimer assay used, as well as the applied reference standard (as over time CTPA has become increasingly more sensitive in fi nding smaller emboli) could all be evaluated as potential modifi ers of the safety and effi ciency of this age-adjusted D -dimer. Th is would provide us valuable information on the subgroup of patients that benefi t most from using this age-adjusted cutoff .
To summarize, the use of an age-adjusted cutoff for D -dimer testing seems to be a promising and safe tool in patients with suspected PE, and the current study by Woller et al 4 reaffi rms this fi nding also in older patients. One of the most promising aspects includes the possibility of reducing the number of CTPA tests required in frail elderly and, thus, also iatrogenic damages (and costs) caused by CTPA. Th is comes at the cost of a small (negligible) increase of missed PE cases. A formal randomized comparison between the age-adjusted and the conventional cutoff for D -dimer testing is preferable to confirm these findings. Yet-before we embark on such a costly and difficult RCT-first more indirect comparisons can be done using IPD meta-analysis, allowing us to better appreciate the potentially huge merits of this age-adjusted cutoff in various subgroups of elderly patients with suspected PE.
